Search Results - Senthilmurugan Ramalingam

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Dissecting major signaling pathways in prostate cancer development and progression: Mechanisms and novel therapeutic targets

    Dissecting major signaling pathways in prostate cancer development and progression: Mechanisms and novel therapeutic targets by Senthilmurugan Ramalingam, Vidya P. Ramamurthy, Vincent C.O. Njar

    Published 2016
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Galeterone and VNPT55 induce proteasomal degradation of AR/AR-V7, induce significant apoptosis via cytochrome c release and suppress growth of castration resistant prostate cancer xenografts<i>in vivo</i>

    Galeterone and VNPT55 induce proteasomal degradation of AR/AR-V7, induce significant apoptosis via cytochrome c release and suppress growth of castration resistant prostate cancer... by Andrew K. Kwegyir‐Afful, Senthilmurugan Ramalingam, Puranik Purushottamachar, Vidya P. Ramamurthy, Vincent C.O. Njar

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    First Mnks degrading agents block phosphorylation of eIF4E, induce apoptosis, inhibit cell growth, migration and invasion in triple negative and Her2-overexpressing breast cancer cell lines

    First Mnks degrading agents block phosphorylation of eIF4E, induce apoptosis, inhibit cell growth, migration and invasion in triple negative and Her2-overexpressing breast cancer c... by Senthilmurugan Ramalingam, Lalji K. Gediya, Andrew K. Kwegyir‐Afful, Vidya P. Ramamurthy, Puranik Purushottamachar, Hannah W. Mbatia, Vincent C.O. Njar

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Systematic Structure Modifications of Multitarget Prostate Cancer Drug Candidate Galeterone To Produce Novel Androgen Receptor Down-Regulating Agents as an Approach to Treatment of Advanced Prostate Cancer

    Systematic Structure Modifications of Multitarget Prostate Cancer Drug Candidate Galeterone To Produce Novel Androgen Receptor Down-Regulating Agents as an Approach to Treatment of... by Puranik Purushottamachar, Abhijit M. Godbole, Lalji K. Gediya, Marlena S. Martin, Tadas S. Vasaitis, Andrew K. Kwegyir‐Afful, Senthilmurugan Ramalingam, Zeynep Ateş‐Alagöz, Vincent C.O. Njar

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Somatic <i>SLC35A2</i> variants in the brain are associated with intractable neocortical epilepsy

    Somatic <i>SLC35A2</i> variants in the brain are associated with intractable neocortical epilepsy by Melodie R. Winawer, Nicole G. Griffin, Jorge Samanamud, Evan H. Baugh, Dinesh Rathakrishnan, Senthilmurugan Ramalingam, David Zagzag, Catherine A. Schevon, Patricia Dugan, Manu Hegde, Sameer A. Sheth, Guy M. McKhann, Werner Doyle, Gerald A. Grant, Brenda E. Porter, Mohamad A. Mikati, Carrie R. Muh, Colin D. Malone, Ann M. Bergin, Jurriaan M. Peters, Danielle McBrian, Alison Pack, Cigdem I. Akman, Christopher M. LaCoursiere, Katherine M. Keever, Joseph R. Madsen, Edward Yang, Hart G.W. Lidov, Catherine Shain, Andrew S. Allen, Peter Canoll, Peter B. Crino, Annapurna Poduri, Erin L. Heinzen

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: